Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

2025December › 05

Wall

7 months ago

The market is awaiting the Federal Reserve's final meeting of 2025, especially what chair Jerome Powell says afterward.
JPMorgan sees shares of Ultragenyx Pharmaceutical soaring more than 200% from current prices.
Under-invested traders continue to get swayed into participating in the market by the fear of missing out, according to Citadel.
Analysts believe that Meta's reported metaverse cuts underline its strong cost discipline and continued focus on efficiency and growth.

page 1 of 1